{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:12:43Z","timestamp":1755216763390,"version":"3.43.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>The objectives of this study were to study the spectrum of neurologic complications in children with lymphoreticular malignancy (acute lymphoblastic leukemia, Hodgkin, and non-Hodgkin lymphoma) at diagnosis and during treatment and to determine the etiology of these complications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods:<\/jats:title>\n            <jats:p>In this descriptive cohort study, conducted between November 2018 and March 2020, 204 children with a diagnosis of lymphoreticular malignancy were enrolled. The baseline investigations were done in all the cases. Those who developed neurological symptoms were evaluated with cerebrospinal fluid examination and radiologic and electrophysiologic studies as per indication and were managed according to standard management guidelines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of the 204 patients, 30 (14.7%) developed neurological complications. The majority of these complications (n=20\/30; 87%) occurred during the intensive chemotherapy period. Common complications included acute methotrexate neurotoxicity (n=7), vincristine-induced neurotoxicity (n=7), central nervous system (CNS) relapse (n=4), and posterior reversible encephalopathy syndrome (n=2). L-asparaginase-induced thrombosis (n=1), intramedullary compression syndrome (n=1), CNS infection (n=2), CNS hemophagocytic lymphohistiocytosis (n=1), and steroid-induced myopathy (n=1) were also observed. The complications resolved in 21\/30 (70%) patients after receiving appropriate treatment while the neurological complication persisted in 2\/30 (6.7%) patients. Three patients (10%) abandoned the treatment, and 4 (13.3%) patients expired.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Neurologic complications in patients with lymphoreticular malignancy are quite variable, having common presenting symptoms but varying imaging abnormalities. By close follow-up and effective treatment, the morbidity and mortality of these complications can be minimized.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000002722","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T09:04:40Z","timestamp":1690880680000},"page":"e885-e891","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Neurologic Complications in Patients With Lymphoreticular Malignancy: A Descriptive Cohort Study"],"prefix":"10.1097","volume":"45","author":[{"given":"Renuka","family":"Baloda","sequence":"first","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suvasini","family":"Sharma","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rama","family":"Anand","sequence":"additional","affiliation":[{"name":"Radiodiagnosis, Kalawati Saran Children's Hospital and Lady Hardinge Medical College, New Delhi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piali","family":"Mandal","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nupur","family":"Parakh","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharat","family":"Katti","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varinder","family":"Singh","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagdish","family":"Chandra","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","article-title":"Childhood acute lymphoblastic leukemia: progress through collaboration","volume":"33","author":"Pui","year":"2015","journal-title":"J ClinOncol"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3109\/10428191003754608","article-title":"Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution","volume":"51","author":"Parasole","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.leukres.2005.09.009","article-title":"The neurologic complications in pediatric acute lymphoblastic leukemia patients excluding leukemic infiltration","volume":"30","author":"Kuskonmaz","year":"2006","journal-title":"Leuk Res"},{"key":"R5-20250804","first-page":"1","article-title":"Acute and long-term neurologic complications in children with acute lymphoblastic leukemia","volume":"48","author":"Aytac","year":"2006","journal-title":"Turk J Pediatr"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00277-010-1150-7","article-title":"Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre-and post-rituximab","volume":"90","author":"Tai","year":"2011","journal-title":"Ann Hematol"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/0971-3026.101080","article-title":"Pictorial essay: acute neurological complications in children with acute lymphoblastic leukemia","volume":"22","author":"Kembhavi","year":"2012","journal-title":"Indian J Radiol Imaging"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/08880018.2019.1637981","article-title":"Incidence of vincristine induced neurotoxicity in children with acute lymphoblastic leukemia and its correlation with nutritional deficiencies","volume":"36","author":"Dudeja","year":"2019","journal-title":"Pediatr Hematol Oncol"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s13312-016-0866-4","article-title":"Intracranial hemorrhage following intrathecal methotrexate therapy for acute lymphoblastic leukaemia","volume":"53","author":"Purkait","year":"2016","journal-title":"Indian Pediatr"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3923\/jpt.2014.129.133","article-title":"PEG asparginase induced superior sagittal sinus thrombosis with status epilepticus pediatric in acute lymphoblastic leukemia (ALL): a report of 2 cases from India","volume":"9","author":"Siddaiahgar","year":"2014","journal-title":"J Pharmacol Toxicol"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/10428194.2021.2012659","article-title":"Risk based and response adapted radiation therapy for children and adolescents with newely diagnosed advanced stage Hodgkin Lymphoma treated with ABVD chemotherapy: a report from the Indian Pediatric Oncology group study InPOG-HL-15-01","volume":"63","author":"Jain","year":"2022","journal-title":"Leuk Lymphoma"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.14319\/ijcto.32.15","article-title":"Pediatric mature B-cell non Hodgkin lymphoma treatment with LMB-96 protocol. The Children Cancer Hospital Egypt experience","volume":"3","author":"Rahman","year":"2015","journal-title":"Int J Cancer Ther Oncol"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/mpo.1149","article-title":"Reversal of neurological disturbances related to high-dose methotrexate by aminophylline","volume":"35","author":"Peyriere","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3329\/bmrcb.v34i3.1858","article-title":"Acute and long-term neurological complications in children with acute lymphoblastic leukemia","volume":"34","author":"Rahman","year":"2008","journal-title":"Bangladesh Med Res Counc Bull"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.pediatrneurol.2015.03.006","article-title":"Acute central nervous system complications in pediatric acute lymphoblastic leukemia","volume":"53","author":"Baytan","year":"2015","journal-title":"Pediatric neurology"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.leukres.2017.12.010","article-title":"Acute and sub-acute neurological toxicity in children treated for acute lymphoblastic leukemia","volume":"65","author":"Millan","year":"2018","journal-title":"Leuk Res"},{"key":"R18-20250804","first-page":"1263","article-title":"Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leuke.mia with high-dose methotrexate","volume":"26","author":"Reddick","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4103\/0973-1482.98993","article-title":"Methotrexate-induced acute toxic leukoencephalopathy","volume":"8","author":"Salkade","year":"2012","journal-title":"J Can Res Ther"},{"key":"R20-20250804","first-page":"1688","article-title":"Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome","volume":"25","author":"Rollins","year":"2004","journal-title":"AJNR Am J Neuroradiol"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0140-6736(95)90464-6","article-title":"Aminophylline for methotrexate-induced neurotoxicity","volume":"345","author":"Bernini","year":"1995","journal-title":"Lancet"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1200\/JCO.1986.4.8.1207","article-title":"Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin\u2019s lymphoma","volume":"4","author":"Morra","year":"1986","journal-title":"J Clin Oncol"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11899-013-0156-3","article-title":"High-dose cytarabine (HD araC) in the treatment of leukemias: a review","volume":"8","author":"Reese","year":"2013","journal-title":"Curr Hematol Malig Rep"},{"key":"R24-20250804","first-page":"323","article-title":"Clinical and electrophysiological studies in vincristine induced neuropathy","volume":"39","author":"Pal","year":"1999","journal-title":"Electromyogr Clin Neurophysiol"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1529-8027.2009.00230.x","article-title":"Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia","volume":"14","author":"Ramchandren","year":"2009","journal-title":"J Peripher Nerv Syst"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.3390\/cancers14143510","article-title":"Genetic polymorphisms associated with vincristine pharmacokinetics and vincristine-induced peripheral neuropathy in pediatric oncology patients","volume":"14","author":"Van de Velde","year":"2022","journal-title":"Cancers"},{"key":"R27-20250804","first-page":"1","article-title":"Posterior reversible encephalopathy syndrome in pediatric cancer: clinical and radiologic findings","volume":"4","author":"Khan","year":"2018","journal-title":"J Glob Oncol"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/pbc.20703","article-title":"Posterior reversible encephalopathy syndrome in children with cancer","volume":"48","author":"Morris","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R29-20250804","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/1097-0142(197604)37:4<1663::AID-CNCR2820370408>3.0.CO;2-7","article-title":"Paraplegia following intrathecal methotrexate: report of a case and review of the literature","volume":"37","author":"Gagliano","year":"1976","journal-title":"Cancer"},{"key":"R30-20250804","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/00006454-198411000-00014","article-title":"Central nervous system toxoplasmosis mimicking a brain abscess in a compromised pediatric patient","volume":"3","author":"Connor","year":"1984","journal-title":"Pediatr Infect Dis"},{"key":"R31-20250804","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/14656566.2019.1701654","article-title":"Pharmacological prophylaxis of infection in pediatric acute myeloid leukemia patients","volume":"21","author":"Arad-Cohen","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"R32-20250804","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/08880019509029552","article-title":"Epidural spinal cord compression as an initial symptom in childhood acute lymphoblastic leukemia: rapid decompression by local irradiation and systemic chemotherapy","volume":"12","author":"Kataoka","year":"1995","journal-title":"Pediatr Hematol Oncol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:07:11Z","timestamp":1754338031000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002722","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2023,7,24]]},"assertion":[{"value":"2022-09-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}